MedPath

Gruppo Italiano Malattie EMatologiche dell'Adulto

🇮🇹Italy
Ownership
Private
Employees
-
Market Cap
-
Website

DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML

Phase 3
Completed
Conditions
AML
Elderly
Interventions
First Posted Date
2008-01-09
Last Posted Date
2008-01-09
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Registration Number
NCT00589082

Adult ALL Treatment at Diagnosis

Not Applicable
Completed
Conditions
Leukemia, Lymphocytic, Acute
First Posted Date
2007-10-01
Last Posted Date
2007-10-01
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Registration Number
NCT00537550
Locations
🇮🇹

Ist.Ematologia e Oncologia Medica L.e A. Seragnoli, Bologna, Italy

🇮🇹

Ospedale Reg. A di Summa, Brindisi, Italy

🇮🇹

Istituto di Ematologia- Ospedale San Carlo, Potenza, Italy

and more 2 locations

Phase III Trial in Acute Promyelocytic Leukemia Patients

Phase 3
Completed
Conditions
Leukemia
Interventions
First Posted Date
2007-06-05
Last Posted Date
2022-10-12
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
276
Registration Number
NCT00482833
Locations
🇦🇹

Universitätsklinik Innsbruck Hämatologie Onkologie, Innsbruck, Austria

🇦🇹

Krankenhaus der Barmherzigen Schwestern Linz, Linz, Austria

🇦🇹

Universitätsklinik für Innere Medizin III Salzburg, Salzburg, Austria

and more 106 locations

Nilotinib as First-line Treatment of Ph+ CML in Early Chronic Phase

Phase 2
Completed
Conditions
Chronic Myeloid Leukemia
First Posted Date
2007-06-01
Last Posted Date
2022-01-18
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
74
Registration Number
NCT00481052
Locations
🇮🇹

Unità Operativa Ematologica - Università degli Studi di Bari, Bari, Italy

🇮🇹

Sezione di Ematologia e Trapianti Spedali Civili, Brescia, Italy

🇮🇹

Ospedale Ferrarotto, Catania, Italy

and more 19 locations

"Geriatric Assessment Adapted" Therapy for Ph- ALL Elderly Patients

Phase 2
Completed
Conditions
Leukemia, Lymphoblastic, Acute
Interventions
Procedure: Geriatric assessment adapted therapy
Procedure: Stem cells autotransplantation
First Posted Date
2007-05-21
Last Posted Date
2022-10-12
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
102
Registration Number
NCT00475280
Locations
🇮🇹

Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli", Napoli, Italy

🇮🇹

USL 8 - Ospedale S.Donato, Arezzo, Italy

🇮🇹

Az. Ospedaliera S. G. Moscati, Avellino, Italy

and more 28 locations

Safety, Tolerability, and Efficacy of Deferasirox in MDS

Phase 3
Completed
Conditions
Hemosiderosis
Myelodysplastic Syndromes
Interventions
First Posted Date
2007-05-04
Last Posted Date
2016-11-22
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
158
Registration Number
NCT00469560
Locations
🇮🇹

SOC EMATOLOGIA ASO SS Antonio e Biagio, Alessandria, Italy

🇮🇹

Clinica Ematologica - Università degli Studi, Genova, Italy

🇮🇹

Clinica Ematol Università di Perugia, Policlinico Monteluce, Perugia, Italy

and more 14 locations

Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia

Phase 2
Completed
Conditions
Leukemia
First Posted Date
2007-04-27
Last Posted Date
2018-08-28
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
57
Registration Number
NCT00466726
Locations
🇮🇹

Ospedali Riuniti di Bergamo, Bergamo, Italy

🇮🇹

Universita Degli Studi di Bari, Bari, Italy

🇮🇹

USD Trapianti di midollo per adulti - Cattedra di Ematologia - Università degli Studi di Brescia, Brescia, Italy

and more 14 locations

Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia

Phase 2
Completed
Conditions
Leukemia
Interventions
Procedure: Transplant
First Posted Date
2007-04-19
Last Posted Date
2013-09-06
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
86
Registration Number
NCT00462332
Locations
🇮🇹

ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE, Lecce, Italy

🇮🇹

Ospedale Regionale A. Pugliese, Catanzaro, Italy

🇮🇹

Universita di Ferrara, Ferrara, Italy

and more 20 locations

Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia

Phase 2
Completed
Conditions
Leukemia
First Posted Date
2007-04-11
Last Posted Date
2019-02-15
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
470
Registration Number
NCT00458848
Locations
🇮🇹

Ospedale S. Donato, Arezzo, Italy

🇮🇹

S.G. Moscati Hospital, Avellino, Italy

🇮🇹

Ospedale Binaghi, Cagliari, Italy

and more 63 locations

AML Treatment in Untreated Adult Patients

Not Applicable
Conditions
Leukemia, Myelocytic, Acute
First Posted Date
2007-03-20
Last Posted Date
2017-11-17
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Registration Number
NCT00449319
Locations
🇮🇹

Dr.ssa Mastrullo, Napoli, Italy

🇮🇹

Prof. D'Arco, Nocera Inferiore, Italy

🇮🇹

Prof. Saglio, Orbassano, Italy

and more 33 locations
© Copyright 2025. All Rights Reserved by MedPath